Browse 19 Biotechnology companies funded by Insight Partners. See funding amounts, founder contacts, and investment details.
ImmuneBridge is developing allogeneic immunotherapies for cancer.
Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.
Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Capacity Bio is a therapeutics company that is focused on mitophagy.
Switch Therapeutics is a biotech company that develops RNAi therapies.
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
Profluent Bio is an AI-first protein design company creating new proteins and gene-editing tools for medicine, agriculture, and science.
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.
Kintsugi detects signs of clinical depression and anxiety using machine learning and voice biomarkers.
View all companies funded by Insight Partners across every industry and funding stage.
View Full Insight Partners Portfolio